{
  "id": 3163893,
  "title": "CHA Biotech wins government backing to advance cell and gene therapy platform",
  "url": "https://urgent.news/2026/08/25/cha-biotech-wins-government-backing-to-advance-cell-and-gene-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-25T02:12:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times",
    "url": "https://www.koreatimes.co.kr/business/companies/20260825/cha-biotech-wins-government-backing-to-advance-cell-and-gene-therapy-platform"
  },
  "original_language": "en",
  "account": null,
  "summary": "CHA Biotech has secured government backing for a three-and-a-half-year research project aimed at advancing its cell and gene therapy platforms toward clinical development. The biotechnology company was selected for a follow-up research and development project under the 2026 K-HERO Development and Support Program, which is led by the Ministry of Science and ICT and administered by the Korea Industrial Technology Association. The funding of 31.5 billion won ($22.7 million) will be used to develop and commercialize two platforms, CHAMS, a standardized source-cell platform based on mesenchymal stem cells, and CHAGE, which uses therapeutic genes to enhance cell function. CHA Biotech plans to combine these platforms into a development system that can be applied across a range of hard-to-treat diseases.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Korea Times",
        "title": "CHA Biotech wins government backing to advance cell and gene therapy platform",
        "url": "https://urgent.news/2026/08/25/cha-biotech-wins-government-backing-to-advance-cell-and-gene-therapy-3165325",
        "published": "2026-08-25T02:17:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}